摘要
目的:评价三磷酸胞苷二钠的安全性和有效性,并与脑活素比较。方法:236例急性脑血管疾病患者随机分成两组,使用三磷酸胞苷二钠和脑活素进行治疗。结果:治疗组和对照组有效率分别为74.2％和50.9％,两者有显著性差异。不良反应率分别为13.3％和19.0％。结论:三磷酸胞苷二钠是治疗急性脑血管病安全有效的药物。
Objective: To compare the efficacy and safety of disodium cytidine triphosphate and cerebrolysin in treatment of acute cerebral vascular disease. Method: Patients with acute cerebral vascular disease were divided into two groups, which were given disodium cytidine triphosphate and cerebrolysin, respectively. Results: The effective rate was 74. 2% in cytridini triphosphatis group and 50.9% in disodium cytidine triphosphate. The incidence rates of side effect of both groups were 13.3% and 19.0%, respectively. There was a significant difference between groups. Conclusion: Disodum cytidine triphosphate is safe and effective in treatment of acute cerebral vascular disease.
出处
《中国药师》
CAS
2002年第1期45-45,共1页
China Pharmacist
关键词
三磷酸胞苷二钠
脑活素
急性脑血管病
疗效
Disodium cytidine triphosphate
Cerebrolysin
Cerebral vascular disease, acute
